Sårkomplikationer efter operation (hyppigst omfattende sternumsår) ses hyppigere i gruppen behandlet med parecoxib/ valdecoxib.
Surgical wound complications (most involving the sternal wound) were observed at an increased rate with parecoxib/ valdecoxib treatment.